Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2019 Results Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Carlo Tanzi - Investor Relations Eric Shaff - President and Chief Executive Officer Matt Henn - Chief Scientific Officer Conference Call Participants Pam Barrett - Cowen Mark Breidenbach - Oppenheimer John Newman - Canaccord Operator Ladies and gentlemen, thank you for standing by and welcome to the Fourth Quarter Seres Therapeutics Earnings Conference Call. At this time, all partici ...